HomecharmnewsA Charming mid-year review: a strong endorsement from Charm clients and the release of CHARM™ Version 4.6

Mid-year Update

A Charming mid-year review: a strong endorsement from Charm clients and the release of CHARM™ Version 4.6

24 December 2015 - As the first half of FY15-16 comes to a close, Charm Health continues to maintain its position as the leading supplier of Medical Oncology eHealth systems in Australia.  Several of the nation’s leading cancer service providers confirmed their confidence in Charm Health by renewing agreements, including; Peter MacCallum Cancer Centre, ACT Health, NSW Health, Fresenius Kabi (WH McCarthy Pty Ltd - now Slade Pharmacy) and Epic Pharmacy. Meanwhile the latest version of  CHARMTM software (version 4.6.0) was released at the end of September offering expanded functionality including components to achieve paperless Closed Loop Medication Management (CLMM) within the oncology setting.

Peter MacCallum Cancer Centre (Peter Mac), a longstanding client of Charm Health, is Australia’s only public hospital solely dedicated to cancer treatment, research and education.  To meet the changing and highly specialised needs of cancer patients and cancer research Peter Mac will be relocated to a new facility within the Victorian Comprehensive Cancer Centre (VCCC) in 2016.   “Charm Health is excited to be supporting the expanded requirements, challenges and opportunities that come with such a visionary program “, commented Gary Lakin, Chief Executive Officer of Charm Health.

Charm Health’s flagship product CHARM™ will continue to be used at the new location.  In addition, work is underway to integrate with systems such as Nexa Q-Flow (appointment management and wayfinder) and Rauland Nurse Call system to ensure optimal workflow efficiencies are achieved on moving to the new facility.

Both Fresenius Kabi (now Slade Pharmacy) and Epic Pharmacy supply chemotherapy drugs and services for patients undergoing cancer treatments and utilise CHARM in what Charm Health refer to as a ‘Pharmacy Only Deployment’ i.e. CHARM is utilised to assist in the manufacturing of chemotherapy rather than as an electronic medical record (EMR) for oncology.  The functions and features of the CHARM Pharmacy module are used to manage clinical reviews, pharmacy worklists for manufacturing, script allocation and PBS requirements.

Both Slade Pharmacy and Epic Pharmacy have undergone significant organisational changes over recent months. Charm Health is pleased to have extended our partnership with both organisations to support their continued growth over the coming years”, said Lakin.

CHARM Version 4.6.0, was released at the end of September. The release contained advanced functionality including an Electronic Medication Administration Record (eMAR), Streamlined Authority Codes that support paperless claiming, and a Cancer Registry Extract for our NSW clients, along with other site specific enhancements.

As an oncology electronic medical record (EMR), CHARM has been progressively developed and enhanced to support increasing levels of Closed Loop Medication Management (CLMM) functionality.  ePrescribing capability has always been at the heart of CHARM functionality. The inclusion of electronic authentication (eSignatures) in CHARM v4.3 further streamlined the prescribing workflow. CHARM also supports pharmacy workflows involving verification and preparation of treatment. Providing support for electronic administration of medicines, through the CHARM medication administration record (eMAR) feature, delivers a comprehensive CLMM solution for medicines management in oncology.

When a CHARM site fully implements the eSignatures and eMAR features and uses CHARM as an Oncology EMR (i.e. to record all relevant clinical information for individual patients) it will have all the components in place to achieve paperless CLMM within the oncology setting. All aspects of prescribing, including verification/supply, administration and information sharing, will exist as an enduring electronic record.

Public hospital pharmacies can now submit ‘paperless’ claims for s100 EFC items. This means the medication chart, rather than a separate prescription on PBS stationery, may be used as the record of the prescription for the claimable item(s). However, the medication chart must comply with certain PBS requirements including display of the Streamlined Authority (SA) approval code. With v4.6.0, CHARM allows for seamless allocation of PBS s100 EFC items that are eligible for claiming as Authority Required (Streamlined) benefits and displaying them on a compliant medication chart. While the primary purpose of this feature is to support public hospital workflows, private providers may choose to activate the functionality to assist with the ordering / dispensing / claiming processes.

“The release of version 4.6.0 shows our commitment to the continued enhancement of CHARM as well as our desire to maintain our position as the leading supplier of Medical Oncology eHealth systems in Australia”, Mr Lakin said.


About Charm Health

Charm Health is Australia’s leading supplier of specialist oncology eHealth systems with 45 successful deployments to Australian public and private cancer care providers since 2000.  In the past decade over 65,000 patients have had their treatment managed using Charm Health solutions.  Charm Health’s flagship product CHARM™ delivers comprehensive multi-site functionality that manages the clinical and administrative coordination of all aspects of a patient’s cancer care. Charm Health solutions mitigate compliance, clinical, financial and administrative risk by ensuring the most up to date patient information is available to all healthcare providers, in real time, when making important clinical and prescribing decisions.

Charm Health is a portfolio company of the OneVentures Innovation Fund.

Read more about Charm Health at:  www.charmhealth.com.au

Media Contact:
Gary Lakin, CEO Charm Health,
Phone +61 7 3512 5305
Email: gary.lakin@charmhealth.com.au